The lung cancer five-year survival rate has increased by nearly 40% in the past decade. Unfortunately, this progress has not been shared equally. Black...
Frost & Sullivan recently assessed the healthcare industry and, based on its findings, recognizes Gleneagles Hospital Kuala Lumpur with the 2023 Malaysia Hospital Customer Value Leadership Award....
Abbott announced that the U.S. Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of chronic back...
Outcomes4Me Inc., the developer of a personalized and evidence-based cancer navigation platform, and the National Comprehensive Cancer Network announced that Outcomes4Me has newly incorporated...
Genentech, a member of the Roche Group , announced positive results from the Phase II FENopta study evaluating investigational oral fenebrutinib in adults with...
